Skip links

Amondys 45™ (casimersen)

Full Name Amondys 45™ (casimersen)
Drug Amondys 45
Manufacturer Sarepta Therapeutics, Inc.
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology
Enrollment Form Link Enrollment Form
Phone Number 800-356-5034
Fax Number 877-339-4602
Product Website